Skip to content
Screener

Bio-Rad Laboratories BIO Life Science — Goodwill, Impaired, Accumulated Impairment Loss

Other segment segments

Clinical Diagnostics
$293.4M0.0%

Similar metrics at other companies

Horace Mann Educators logo
HMNLife & Retirement — Goodwill, Impaired, Accumulated Impairment Loss
$35.6M0.0%
Freedom Holding logo
FRHCBrokerage — Goodwill, Impaired, Accumulated Impairment Loss
$0
Freedom Holding logo
FRHCInsurance — Goodwill, Impaired, Accumulated Impairment Loss
$0
Freedom Holding logo
FRHCOther — Goodwill, Impaired, Accumulated Impairment Loss
$0
AES logo
AESRenewables — Goodwill, Impaired, Accumulated Impairment Loss
$35M0.0%
AES logo
AESUtilities — Goodwill, Impaired, Accumulated Impairment Loss
$2.71B0.0%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Balances as of December 31, 2025Life ScienceClinical DiagnosticsTotal
Goodwill$493.2$421.8$915.0
Accumulated impairment losses(41.8)(293.4)(335.2)
Goodwill, net451.4128.4579.8
Foreign currency adjustments(2.7)(2.7)
Period change, net(2.7)(2.7)
Balances as of March 31, 2026
Goodwill490.5421.8912.3
Accumulated impairment losses(41.8)(293.4)(335.2)

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss?
Bio-Rad Laboratories (BIO) reported life science — goodwill, impaired, accumulated impairment loss of $41.8M in Q1 2026.
How has Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss changed year-over-year?
Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss decreased by 0.0% year-over-year, from $41.8M to $41.8M.
What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss has grown at a 0.0% compound annual growth rate (CAGR), from $167.2M to $167.2M.
What does life science — goodwill, impaired, accumulated impairment loss mean?
The cumulative amount of impairment losses recognized against the goodwill of the Life Science segment. This reflects historical write-downs taken when the carrying value of the segment's goodwill exceeded its implied fair value.

Ask your AI about Bio-Rad Laboratories's life science — goodwill, impaired, accumulated impairment loss.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude